Cheng-Ming Chiang

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 18

Top Topics

Breast Cancer Cells

Respiratory Syncytial Virus

Top Venues

ACS pharmacology & translational science

Journal of medicinal chemistry

Medicinal research reviews

This page only lists publications with an associated author ORCID identifier.

Publications

Shumei Wang, Kang Lei, Hsien-Tsung Lai, Tingting Liu, Lupei Du, Shwu-Yuan Wu, Xiaohan Ye, Cheng-Ming Chiang, Mingliang Yuan
Novel BRD4-p53 Inhibitor SDU-071 Suppresses Proliferation and Migration of MDA-MB-231 Triple-Negative Breast Cancer Cells. ACS pharmacology & translational science 7 (4) (2024)
Dipanwita Das, Jia Yu Leung, Shivaranjani Balamurugan, Vinay Tergaonkar, Amos Hong Pheng Loh, Cheng-Ming Chiang, Reshma Taneja
BRD4 isoforms have distinct roles in tumour progression and metastasis in rhabdomyosarcoma. EMBO reports 25 (2) (2024)
Dipanwita Das, Jia Yu Leung, Shivaranjani Balamurugan, Vinay Tergaonkar, Amos Hong Pheng Loh, Cheng-Ming Chiang, Reshma Taneja
BRD4 isoforms have distinct roles in tumour progression and metastasis in rhabdomyosarcoma. EMBO reports (2024)
Dipanwita Das, Jia Yu Leung, Shivaranjani Balamurugan, Vinay Tergaonkar, Amos Hong Pheng Loh, Cheng-Ming Chiang, Reshma Taneja
BRD4 isoforms have distinct roles in tumour progression and metastasis in rhabdomyosarcoma. EMBO reports 25 (2) (2024)
Dipanwita Das, Jia Yu Leung, Shivaranjani Balamurugan, Vinay Tergaonkar, Amos Hong Pheng Loh, Cheng-Ming Chiang, Reshma Taneja
BRD4 isoforms have distinct roles in tumour progression and metastasis in rhabdomyosarcoma. EMBO reports 25 (2) (2024)
Dipanwita Das, Jia Yu Leung, Shivaranjani Balamurugan, Vinay Tergaonkar, Amos Hong Pheng Loh, Cheng-Ming Chiang, Reshma Taneja
BRD4 isoforms have distinct roles in tumour progression and metastasis in rhabdomyosarcoma. EMBO reports 25 (2) (2024)
Dipanwita Das, Jia Yu Leung, Shivaranjani Balamurugan, Vinay Tergaonkar, Amos Hong Pheng Loh, Cheng-Ming Chiang, Reshma Taneja
BRD4 isoforms have distinct roles in tumour progression and metastasis in rhabdomyosarcoma. EMBO reports (2024)
Shumei Wang, Kang Lei, Hsien-Tsung Lai, Tingting Liu, Lupei Du, Shwu-Yuan Wu, Xiaohan Ye, Cheng-Ming Chiang, Mingliang Yuan
Novel BRD4-p53 Inhibitor SDU-071 Suppresses Proliferation and Migration of MDA-MB-231 Triple-Negative Breast Cancer Cells. ACS pharmacology & translational science 7 (4) (2024)
Dipanwita Das, Jia Yu Leung, Shivaranjani Balamurugan, Vinay Tergaonkar, Amos Hong Pheng Loh, Cheng-Ming Chiang, Reshma Taneja
BRD4 isoforms have distinct roles in tumour progression and metastasis in rhabdomyosarcoma. EMBO reports (2024)
Shumei Wang, Kang Lei, Hsien-Tsung Lai, Tingting Liu, Lupei Du, Shwu-Yuan Wu, Xiaohan Ye, Cheng-Ming Chiang, Mingliang Yuan
Novel BRD4-p53 Inhibitor SDU-071 Suppresses Proliferation and Migration of MDA-MB-231 Triple-Negative Breast Cancer Cells. ACS pharmacology & translational science 7 (4) (2024)
Shumei Wang, Kang Lei, Hsien-Tsung Lai, Tingting Liu, Lupei Du, Shwu-Yuan Wu, Xiaohan Ye, Cheng-Ming Chiang, Mingliang Yuan
Novel BRD4-p53 Inhibitor SDU-071 Suppresses Proliferation and Migration of MDA-MB-231 Triple-Negative Breast Cancer Cells. ACS pharmacology & translational science 7 (4) (2024)
Dipanwita Das, Jia Yu Leung, Shivaranjani Balamurugan, Vinay Tergaonkar, Amos Hong Pheng Loh, Cheng-Ming Chiang, Reshma Taneja
BRD4 isoforms have distinct roles in tumour progression and metastasis in rhabdomyosarcoma. EMBO reports 25 (2) (2024)
Dipanwita Das, Jia Yu Leung, Vinay Tergaonkar, Amos Hong Pheng Loh, Cheng-Ming Chiang, Reshma Taneja
BRD4 isoforms have distinct roles in tumor progression and metastasis in embryonal rhabdomyosarcoma. bioRxiv : the preprint server for biology (2023)
Hui Yang, Pinpin Sui, Ying Guo, Shi Chen, Marie E Maloof, Guo Ge, Francine Nihozeko, Caroline R D Xavier Paul Ezhilan, Ganqian Zhu, Peng Zhang, Zhenqing Ye, Edward A Medina, Nagi G Ayad, Ruben Mesa, Stephen D Nimer, Cheng-Ming Chiang, Mingjiang Xu, Yidong Chen, Feng-Chun Yang
Loss of BRD4 induces cell senescence in HSC/HPCs by deregulating histone H3 clipping. EMBO reports (2023)
Jingjing Cao, Menghan Shi, Lina Zhu, Xiangzhi Li, Aiying Li, Shwu-Yuan Wu, Cheng-Ming Chiang, Youming Zhang
The matrix protein of respiratory syncytial virus suppresses interferon signaling via RACK1 association. Journal of virology (2023)
Zhi-Qing Liu, Yi Li, Haiying Chen, Hsien-Tsung Lai, Pingyuan Wang, Shwu-Yuan Wu, Eric A Wold, Paul G Leonard, Sarah Joseph, Haitao Hu, Cheng-Ming Chiang, Allan R Brasier, Bing Tian, Jia Zhou
Discovery, X-ray Crystallography, and Anti-inflammatory Activity of Bromodomain-containing Protein 4 (BRD4) BD1 Inhibitors Targeting a Distinct New Binding Site. Journal of medicinal chemistry 65 (3) (2022)
Lu Feng, Guan Wang, Yi Chen, Gu He, Bo Liu, Jie Liu, Cheng-Ming Chiang, Liang Ouyang
Dual-target inhibitors of bromodomain and extra-terminal proteins in cancer: A review from medicinal chemistry perspectives. Medicinal research reviews (2021)
Jifa Zhang, Pan Tang, Ling Zou, Jin Zhang, Juncheng Chen, Chengcan Yang, Gu He, Bo Liu, Jie Liu, Cheng-Ming Chiang, Guan Wang, Tinghong Ye, Liang Ouyang
Discovery of Novel Dual-Target Inhibitor of Bromodomain-Containing Protein 4/Casein Kinase 2 Inducing Apoptosis and Autophagy-Associated Cell Death for Triple-Negative Breast Cancer Therapy. Journal of medicinal chemistry 64 (24) (2021)